Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 11, 2019

KRAIG BIOCRAFT LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Wyoming				83-0458707
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2723 South State St. Suite 150

Ann Arbor, Michigan 48104

(Address of principal executive offices, including Zip Code)

(734) 619-8066

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		-		-

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (?230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01: Regulation FD Disclosure

On or about July 13, 2019, Kraig Biocraft Laboratories, Inc. (the “Company”) will complete the mailings of notice to its shareholders regarding the Company’s upcoming annual shareholder meeting. The shareholder meeting will be held at 10:00 a.m., eastern standard time, at East Lansing Marriott at University Place, 300 M. A. C. Ave, East Lansing, MI 48823, on July 24, 2019, for the purpose of considering and voting upon several proposals, as set forth in the notice, which is attached hereto as Exhibit 99.1

The notice and related proxy card will be mailed to each shareholder entitled to vote at the annual meeting. Shareholders are urged to read the entire notice as it contains important information about the proposed corporate actions.

After the annual meeting, we will file an amendment to this Report to disclose the voting results.

The information included in Item 7.01 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 , as amended (the “Securities Act”), or the Exchange Act , except as expressly set forth by specific reference in such filing.

Item 8.01

Other Events.

On July 8, 2019, the Company issued a press release announcing the annual shareholder meeting and related information. A copy of the press release is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.	Description
99.1	Notice to Shareholders
99.2	Press Release

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 11, 2019